GO ID | GO:0030308 |
Ontology | BP |
GO Term | negative regulation of cell growth |
Definition | Any process that stops, prevents, or reduces the frequency, rate, extent or direction of cell growth. |
Gene Symbol | Description | Entrez ID | Uniprot ID | Chromosomal Location |
---|---|---|---|---|
APBB1 |
amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) |
322 |
O00213 |
chr11: 6,395,124-6,419,414 |
DDX3X |
DEAD (Asp-Glu-Ala-Asp) box helicase 3, X-linked |
1654 |
O00571 |
chrX: 41,333,348-41,364,472 |
CYP27B1 |
cytochrome P450 family 27 subfamily B member 1 |
1594 |
O15528 |
chr12: 57,762,334-57,768,986 |
GDF9 |
growth differentiation factor 9 |
2661 |
O60383 |
chr5: 132,861,181-132,866,884 |
GREM1 |
gremlin 1, DAN family BMP antagonist |
26585 |
O60565 |
chr15: 32,717,974-32,745,107 |
NME6 |
NME/NM23 nucleoside diphosphate kinase 6 |
10201 |
O75414 |
chr3: 48,293,264-48,301,685 |
SLIT2 |
slit guidance ligand 2 |
9353 |
O94813 |
chr4: 20,253,260-20,620,561 |
BMP10 |
bone morphogenetic protein 10 |
27302 |
O95393 |
chr2: 68,865,481-68,871,517 |
AGT |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
183 |
P01019 |
chr1: 230,702,523-230,714,297 |
TGFB1 |
transforming growth factor beta 1 |
7040 |
P01137 |
chr19: 41,301,587-41,353,911 |
CRYAB |
crystallin alpha B |
1410 |
P02511 |
chr11: 111,908,565-111,923,722 |
TP53 |
tumor protein p53 |
7157 |
P04637 |
chr17: 7,661,779-7,687,550 |
ENO1 |
enolase 1, (alpha) |
2023 |
P06733 |
chr1: 8,861,002-8,879,249 |
SERPINE2 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 |
5270 |
P07093 |
chr2: 223,975,112-224,039,319 |
INHBA |
inhibin beta A |
3624 |
P08476 |
chr7: 41,667,168-41,705,834 |
FBP1 |
fructose-bisphosphatase 1 |
2203 |
P09467 |
chr9: 94,603,133-94,640,249 |
BCL2 |
B-cell CLL/lymphoma 2 |
596 |
P10415 |
chr18: 63,123,346-63,320,128 |
NPPB |
natriuretic peptide B |
4879 |
P16860 |
chr1: 11,857,464-11,858,931 |
GJA1 |
gap junction protein alpha 1 |
2697 |
P17302 |
chr6: 121,435,692-121,449,727 |
WT1 |
Wilms tumor 1 |
7490 |
P19544 |
chr11: 32,387,775-32,435,630 |
ENPP1 |
ectonucleotide pyrophosphatase/phosphodiesterase 1 |
5167 |
P22413 |
chr6: 131,808,016-131,895,155 |
MT3 |
metallothionein 3 |
4504 |
P25713 |
chr16: 56,589,074-56,591,088 |
PPP2R1A |
protein phosphatase 2 regulatory subunit A, alpha |
5518 |
P30153 |
chr19: 52,190,039-52,229,533 |
PHB |
prohibitin |
5245 |
P35232 |
chr17: 49,404,049-49,414,905 |
ACVR1B |
activin A receptor type IB |
91 |
P36896 |
chr12: 51,951,667-51,997,078 |
PPARG |
peroxisome proliferator-activated receptor gamma |
5468 |
P37231 |
chr3: 12,287,368-12,434,356 |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
1026 |
P38936 |
chr6: 36,676,460-36,687,339 |
BCL6 |
B-cell CLL/lymphoma 6 |
604 |
P41182 |
chr3: 187,721,377-187,745,727 |
CDKN2C |
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) |
1031 |
P42773 |
chr1: 50,960,745-50,974,633 |
CDKN1B |
cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
1027 |
P46527 |
chr12: 12,715,058-12,722,371 |
AGTR2 |
angiotensin II receptor, type 2 |
186 |
P50052 |
chrX: 116,170,722-116,174,972 |
GNG4 |
guanine nucleotide binding protein (G protein), gamma 4 |
2786 |
P50150 |
chr1: 235,547,687-235,650,754 |
PPT1 |
palmitoyl-protein thioesterase 1 |
5538 |
P50897 |
chr1: 40,071,461-40,097,727 |
SMARCA2 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
6595 |
P51531 |
chr9: 1,980,290-2,193,624 |
SMARCA4 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 |
6597 |
P51532 |
chr19: 10,961,001-11,065,395 |
SESN2 |
sestrin 2 |
83667 |
P58004 |
chr1: 28,259,527-28,282,491 |
TGFB2 |
transforming growth factor beta 2 |
7042 |
P61812 |
chr1: 218,346,235-218,444,619 |
BTG1 |
B-cell translocation gene 1, anti-proliferative |
694 |
P62324 |
chr12: 92,140,278-92,145,897 |
RACK1 |
guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1 |
10399 |
P63244 |
chr5: 181,236,909-181,248,096 |
SMAD3 |
SMAD family member 3 |
4088 |
P84022 |
chr15: 67,063,763-67,195,195 |
FOXK1 |
forkhead box K1 |
221937 |
P85037 |
chr7: 4,682,309-4,771,443 |
PPARD |
peroxisome proliferator-activated receptor delta |
5467 |
Q03181 |
chr6: 35,342,558-35,428,191 |
BST2 |
bone marrow stromal cell antigen 2 |
684 |
Q10589 |
chr19: 17,402,939-17,405,648 |
HYAL2 |
hyaluronoglucosaminidase 2 |
8692 |
Q12891 |
chr3: 50,317,790-50,322,906 |
PTPRJ |
protein tyrosine phosphatase, receptor type, J |
5795 |
Q12913 |
chr11: 47,980,558-48,170,841 |
SMAD4 |
SMAD family member 4 |
4089 |
Q13485 |
chr18: 51,028,394-51,085,045 |
FHL1 |
four and a half LIM domains 1 |
2273 |
Q13642 |
chrX: 136,146,702-136,211,359 |
BMPR2 |
bone morphogenetic protein receptor type II |
659 |
Q13873 |
chr2: 202,376,936-202,567,751 |
STK11 |
serine/threonine kinase 11 |
6794 |
Q15831 |
chr19: 1,177,558-1,228,435 |
CCDC85B |
coiled-coil domain containing 85B |
11007 |
Q15834 |
chr11: 65,890,112-65,891,635 |
JADE1 |
jade family PHD finger 1 |
79960 |
Q6IE81 |
chr4: 128,809,623-128,875,224 |
PSRC1 |
proline/serine-rich coiled-coil 1 |
84722 |
Q6PGN9 |
chr1: 109,279,556-109,283,186 |
ADIPOR2 |
adiponectin receptor 2 |
79602 |
Q86V24 |
chr12: 1,688,574-1,788,678 |
CRLF3 |
cytokine receptor-like factor 3 |
51379 |
Q8IUI8 |
chr17: 30,769,388-30,824,776 |
CCAR2 |
cell cycle and apoptosis regulator 2 |
57805 |
Q8N163 |
chr8: 22,604,632-22,621,514 |
SFRP1 |
secreted frizzled-related protein 1 |
6422 |
Q8N474 |
chr8: 41,261,958-41,309,497 |
FLCN |
folliculin |
201163 |
Q8NFG4 |
chr17: 17,212,212-17,237,188 |
ESR2 |
estrogen receptor 2 (ER beta) |
2100 |
Q92731 |
chr14: 64,084,232-64,338,112 |
APBB2 |
amyloid beta (A4) precursor protein-binding, family B, member 2 |
323 |
Q92870 |
chr4: 40,810,027-41,216,714 |
ADIPOR1 |
adiponectin receptor 1 |
51094 |
Q96A54 |
chr1: 202,940,823-202,958,572 |
RERG |
RAS-like, estrogen-regulated, growth inhibitor |
85004 |
Q96A58 |
chr12: 15,107,783-15,348,675 |
DACT3 |
dishevelled-binding antagonist of beta-catenin 3 |
147906 |
Q96B18 |
chr19: 46,647,612-46,661,138 |
DCBLD2 |
discoidin, CUB and LCCL domain containing 2 |
131566 |
Q96PD2 |
chr3: 98,795,941-98,901,689 |
TSPYL2 |
TSPY-like 2 |
64061 |
Q9H2G4 |
chrX: 53,082,367-53,088,540 |
SOX17 |
SRY-box 17 |
64321 |
Q9H6I2 |
chr8: 54,457,935-54,460,888 |
WFDC1 |
WAP four-disulfide core domain 1 |
58189 |
Q9HC57 |
chr16: 84,294,646-84,329,851 |
RTN4 |
reticulon 4 |
57142 |
Q9NQC3 |
chr2: 54,972,187-55,112,621 |
CDKN2AIP |
CDKN2A interacting protein |
55602 |
Q9NXV6 |
chr4: 183,444,591-183,448,198 |
NDUFA13 |
NADH:ubiquinone oxidoreductase subunit A13 |
51079 |
Q9P0J0 |
chr19: 19,515,736-19,529,054 |
SH3BP4 |
SH3-domain binding protein 4 |
23677 |
Q9P0V3 |
chr2: 234,951,973-235,055,714 |
IP6K2 |
inositol hexakisphosphate kinase 2 |
51447 |
Q9UHH9 |
chr3: 48,688,003-48,740,353 |
OSGIN1 |
oxidative stress induced growth inhibitor 1 |
29948 |
Q9UJX0 |
chr16: 83,948,282-83,966,332 |